138 related articles for article (PubMed ID: 23023447)
1. Comparison between CT and CEUS in the diagnosis of pancreatic adenocarcinoma.
D'Onofrio M; Crosara S; Signorini M; De Robertis R; Canestrini S; Principe F; Pozzi Mucelli R
Ultraschall Med; 2013 Aug; 34(4):377-81. PubMed ID: 23023447
[TBL] [Abstract][Full Text] [Related]
2. Application of contrast-enhanced ultrasound in the diagnosis of solid pancreatic lesions--a comparison of conventional ultrasound and contrast-enhanced CT.
Fan Z; Li Y; Yan K; Wu W; Yin S; Yang W; Xing B; Li X; Zhang X
Eur J Radiol; 2013 Sep; 82(9):1385-90. PubMed ID: 23727375
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced ultrasonography better identifies pancreatic tumor vascularization than helical CT.
D'Onofrio M; Malagò R; Zamboni G; Vasori S; Falconi M; Capelli P; Mansueto G
Pancreatology; 2005; 5(4-5):398-402. PubMed ID: 15985763
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of multi-detector computed tomography, fluorodeoxyglucose positron emission tomography-CT, and CA 19-9 levels in detecting recurrent pancreatic adenocarcinoma.
Hamidian Jahromi A; Sangster G; Zibari G; Martin B; Chu Q; Takalkar A; Shi R; Shokouh-Amiri H
JOP; 2013 Jul; 14(4):466-8. PubMed ID: 23846950
[TBL] [Abstract][Full Text] [Related]
5. Comparison of double contrast-enhanced ultrasound and MDCT for assessing vascular involvement of pancreatic adenocarcinoma: preliminary results correlated with surgical findings.
Li S; Huang P; Xu H; Xu K; Wu X
Ultraschall Med; 2012 Dec; 33(7):E299-E305. PubMed ID: 22549812
[TBL] [Abstract][Full Text] [Related]
6. Prediction of vascular involvement and resectability by multidetector-row CT versus MR imaging with MR angiography in patients who underwent surgery for resection of pancreatic ductal adenocarcinoma.
Lee JK; Kim AY; Kim PN; Lee MG; Ha HK
Eur J Radiol; 2010 Feb; 73(2):310-6. PubMed ID: 19070981
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Multidetector CT and Gadobutrol-Enhanced MR Imaging for Evaluation of Small, Solid Pancreatic Lesions.
Choi TW; Lee JM; Kim JH; Yu MH; Han JK; Choi BI
Korean J Radiol; 2016; 17(4):509-21. PubMed ID: 27390542
[TBL] [Abstract][Full Text] [Related]
8. Can contrast-enhanced ultrasonography replace multidetector-computed tomography in the detection of liver metastases from colorectal cancer?
Larsen LP; Rosenkilde M; Christensen H; Bang N; Bolvig L; Christiansen T; Laurberg S
Eur J Radiol; 2009 Feb; 69(2):308-13. PubMed ID: 18068925
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of contrast-enhanced transabdominal ultrasound for tumor classification and tumor staging in the pancreatic head.
Grossjohann HS; Rappeport ED; Jensen C; Svendsen LB; Hillingsø JG; Hansen CP; Nielsen MB
Scand J Gastroenterol; 2010 Aug; 45(7-8):917-24. PubMed ID: 20441527
[TBL] [Abstract][Full Text] [Related]
10. Transabdominal contrast-enhanced ultrasonography of pancreatic cancer.
Kersting S; Roth J; Bunk A
Pancreatology; 2011; 11 Suppl 2():20-7. PubMed ID: 21464583
[TBL] [Abstract][Full Text] [Related]
11. Blunt abdominal trauma: role of contrast-enhanced ultrasound (CEUS) in the detection and staging of abdominal traumatic lesions compared to US and CE-MDCT.
Sessa B; Trinci M; Ianniello S; Menichini G; Galluzzo M; Miele V
Radiol Med; 2015 Feb; 120(2):180-9. PubMed ID: 24961341
[TBL] [Abstract][Full Text] [Related]
12. Enhancement pattern of small hepatocellular carcinoma (HCC) at contrast-enhanced US (CEUS), MDCT, and MRI: intermodality agreement and comparison of diagnostic sensitivity between 2005 and 2010 American Association for the Study of Liver Diseases (AASLD) guidelines.
Furlan A; Marin D; Cabassa P; Taibbi A; Brunelli E; Agnello F; Lagalla R; Brancatelli G
Eur J Radiol; 2012 Sep; 81(9):2099-105. PubMed ID: 21906896
[TBL] [Abstract][Full Text] [Related]
13. CEUS of the pancreas: Still research or the standard of care.
D'Onofrio M; Canestrini S; De Robertis R; Crosara S; Demozzi E; Ciaravino V; Pozzi Mucelli R
Eur J Radiol; 2015 Sep; 84(9):1644-9. PubMed ID: 25796427
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of focal liver lesions undetermined at grey-scale US: contrast-enhanced US versus 64-row MDCT and MRI with liver-specific contrast agent.
Bartolotta TV; Taibbi A; Midiri M; La Grutta L; De Maria M; Lagalla R
Radiol Med; 2010 Aug; 115(5):714-31. PubMed ID: 20082225
[TBL] [Abstract][Full Text] [Related]
15. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
Seitz K; Strobel D; Bernatik T; Blank W; Friedrich-Rust M; Herbay Av; Dietrich CF; Strunk H; Kratzer W; Schuler A
Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670
[TBL] [Abstract][Full Text] [Related]
16. Characterization by biopsy or CEUS of liver lesions guided by image fusion between ultrasonography and CT, PET/CT or MRI.
Ewertsen C; Henriksen BM; Torp-Pedersen S; Bachmann Nielsen M
Ultraschall Med; 2011 Apr; 32(2):191-7. PubMed ID: 21225564
[TBL] [Abstract][Full Text] [Related]
17. Contrast enhanced transabdominal ultrasound in the characterisation of pancreatic lesions with cystic appearance.
Beyer-Enke SA; Hocke M; Ignee A; Braden B; Dietrich CF
JOP; 2010 Sep; 11(5):427-33. PubMed ID: 20818109
[TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced ultrasound for diagnosing, staging and assessment of operability of pancreatic cancer.
Grossjohann HS
Dan Med J; 2012 Dec; 59(12):B4536. PubMed ID: 23290292
[TBL] [Abstract][Full Text] [Related]
19. Preoperative Tumor Staging of Gastric Cancer: Comparison of Double Contrast-Enhanced Ultrasound and Multidetector Computed Tomography.
He P; Miao LY; Ge HY; Wang TL; Ye JX; Meng LM; Xue H; Zhang F; Zhao B
J Ultrasound Med; 2019 Dec; 38(12):3203-3209. PubMed ID: 31115090
[TBL] [Abstract][Full Text] [Related]
20. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
